Patent Grant
11857486
The vast majority of patients treated with conventional (C) cardiopulmonary resuscitation (CPR) never wake up after cardiac arrest. Traditional closed-chest CPR involves repetitively compressing the chest in the med-sternal region with a patient supine in an effort to propel blood out of the non-beating heart to the brain and other vital organs. This method is not very efficient, in part because refilling of the heart is dependent upon the generation of an intrathoracic vacuum during the decompression phase that draws blood back to the heart. C-CPR typically provides only 15-30% of normal blood flow to the brain and heart. In addition, with each chest compression, the arterial pressure increases immediately. Similarly, with each chest compression, right-side heart pressures rise to levels nearly identical to those observed on the arterial side. The high right-sided pressures are in turn transmitted to the brain via the paravertebral venous plexus and jugular veins. This increase in blood volume and pressure with each chest compression in the setting of impaired cerebral perfusion further increases intracranial pressure (ICP), thereby reducing cerebral perfusion. In addition, the simultaneous rise of arterial and venous pressure with each C-CPR compression generates contemporaneous bi-directional (venous and arterial) high pressure compression waves that bombard the brain within the closed-space of the skull. This has the potential to further reduce brain perfusion and cause additional damage to the already ischemic brain tissue during C-CPR.
To address these limitations, newer methods of CPR have been developed that significantly augment cerebral and cardiac perfusion, lower intracranial pressure during the decompression phase of CPR, and improve short and long-term outcomes. These methods may include the use of active compression decompression (ACD)+CPR, an impedance threshold device (ITD), and/or combinations thereof. However, despite these advances, most patients still do not wake up after out-of-hospital cardiac arrest.
Embodiments of the invention are directed toward systems and methods of administering CPR to a patient in a head and thorax up position. Such techniques result in lower right-atrial pressures and intracranial pressure while increasing cerebral perfusion pressure, cerebral output, and systolic blood pressure (SBP) compared to CPR administered to an individual in the supine position. The configuration may also preserve a central blood volume and lower pulmonary vascular resistance. This provides a more effective and safe method of performing CPR for extended periods of time. The head and thorax up configuration may also preserve the patient in the sniffing position to optimize airway management.
In one aspect, a method of performing CPR is provided. The method may include elevating the thorax of an individual to a first height relative to a lower body of the individual. The head of the individual may be elevated to a second height relative to the lower body of the individual. The second height may be greater than the first height. CPR may be performed by repeatedly compressing the chest. By elevating the thorax and by also elevating the head to a greater height than the thorax, intracranial pressures may be lowered and cerebral perfusion pressure increased during the performance of CPR. Elevation of the torso and head in this manner may also lower the right atrial pressure and increase coronary perfusion pressure during the performance of CPR. In some cases, the intrathoracic pressure of the individual may also be regulated while performing CPR. In some embodiments, the first height may be between about 3 cm and 8 cm, and the second height may be between about 10 cm and 30 cm.
In another aspect, a method for performing CPR may involve the step of elevating the heart of an individual to a first height relative to a lower body of the individual (with the lower body being in a substantially horizontal plane). The method may also include elevating the head of the individual to a second height relative to the lower body of the individual. The second height may be greater than the first height. With the body in this orientation, any one of a variety of CPR procedures may be performed. In some cases, any one of a variety of intrathoracic pressure regulation procedures may also be performed in combination with the performance of CPR. The first height and the second height may be determined based on one or both of the type of CPR or the type of intrathoracic pressure regulation or some type of physiological feedback [e.g. blood pressure].
In another aspect, a method for performing CPR includes elevating the heart of an individual at a first angle relative to a lower body of the individual. The lower body may be in a substantially horizontal plane. The method may also include elevating the head of the individual at a second angle relative to the lower body such that the head is elevated above the heart. The method may further include performing CPR by repeatedly compressing the chest. In this manner, elevation of the heart and elevation of the head to a greater height than the thorax assists to 1) lower intracranial pressure and increase cerebral perfusion pressure during the performance of CPR and 2) lower right atrial pressure and increase coronary perfusion pressure during the performance of CPR. The method may include regulating the intrathoracic pressure of the individual while performing CPR by multiple potential means including, but not limited to, active compression decompression CPR, an impedance threshold device, actively withdrawing respiratory gases from the thorax between each positive pressure ventilation, load-distributing band CPR, and/or some combination of these approaches.
In another aspect, a system for performing CPR is provided. The system may include a support structure configured to elevate a head and a heart of an individual above a lower body of the individual. The lower body may be in a substantially horizontal plane. The heart may be elevated by the support structure to between about 3 and 8 cm above the substantially horizontal plane and the head may be elevated between about 10 and 30 cm above the substantially horizontal plane.
In some cases, the support structure may also include some type of connector or coupling mechanism that permits a CPR assist device to be easily coupled to the support structure. For example, the connector or coupling mechanism could be configured to receive a CPR compression device or compression vest that is used to compress and/or decompress the chest while the torso and head are elevated. Other mechanisms could be used to connect some type of intrathoracic pressure regulation device as well.
In some cases a CPR compression device capable of compressing the thorax, and in some cases actively decompressing the chest, is attached to the structure that elevates the thorax such that when the thorax is elevated the compression device is able to compress the chest at right angles to the plane of the body. In some cases the structure that elevates the thorax is capable of elevating the thorax at a different angle than the part of the structure that elevates the head.
In another aspect, a system for performing CPR may include a support structure having a first portion configured to elevate a heart of an individual above a lower body of the individual and a second portion configured to elevate a head of the individual above the lower body. The lower body may be in a substantially horizontal plane. The system may also include a mounting disposed on the first portion. The mounting may be configured to removably couple a chest compression device to the first portion such that the chest compression device is coupleable to the mounting to deliver chest compressions to the individual at a substantially perpendicular angle to the first portion. The system may further include a first adjustment mechanism configured to adjust an angle of the first portion between about 3 degrees and 30 degrees relative to the substantially horizontal plane and a second adjustment mechanism configured to adjust an angle of the second portion between about 15 degrees and 45 degrees relative to the substantially horizontal plane.
In some embodiments, the system may include a neck support configured to maintain a position of the individual relative to the support structure such that the individual is properly situated in the “sniffing position” for ventilation, airway management, and for endotracheal intubation. A position of the neck support may be adjustable relative to the support structure. Adjustments of the neck support and one or both of the angle of the first portion or the angle of the second portion may be synchronized such that the individual is properly situated in the “sniffing position” for ventilation, airway management, and for endotracheal intubation throughout the adjustments. A size and/or a shape of the neck support may also be adjustable. In some embodiments, a pivot point of the first portion is coincident with a pivot point of the individual's upper body. The individual's pivot point may be in the region of the spinal axis and the scapula region.
One aspect of the invention involves CPR techniques where the entire body of a patient is tilted upward. This improves cerebral perfusion and cerebral perfusion pressures after cardiac arrest and up to 8 minutes of CPR and may be done using a combination any one of a variety of automated C-CPR devices and/or any one of a variety of systems for regulating intrathoracic pressure, such as a threshold valve that is interfaces with a patient's airway (e.g., an ITD). With conventional head up CPR, gravity drains venous blood from the brain to the heart, resulting in refilling of the heart after each compression and a substantial decrease in ICP, thereby reducing resistance to forward brain flow. This maneuver also reduces the likelihood of simultaneous high pressure waveform simultaneously compressing the brain during the compression phase. While this may represent a potential significant advance, tilting the entire body upward has the potential to reduce coronary and cerebral perfusion during a prolonged resuscitation effort since over time gravity will cause the redistribution of blood to the abdomen and lower extremities. It is known that the average duration of CPR is over 20 minutes for many patients with out-of-hospital cardiac arrest.
To prolong the elevation of the cerebral and coronary perfusion pressures sufficiently for longer resuscitation efforts, the head may be elevated at between about 10 cm and 30 cm (typically about 15 cm) while the thorax, specifically the heart and/or lungs, is elevated at between about 3 cm and 8 cm (typically about 4 cm) relative to a supporting surface and/or a lower body of the individual. In this way, the difference in height between the head and the heart may be in the range of about 7 cm to about 27 cm. Typically, this involves providing a thorax support and a head support that are configured to elevate the respective portions of the body at different angles and/or heights to achieve the desired elevation with the head raised higher than the thorax and the thorax raised higher than the lower body of the individual being treated. Such a configuration may result in lower right-atrial pressures while increasing cerebral perfusion pressure, cerebral output, and systolic blood pressure SBP compared to CPR administered to an individual in the supine position. The configuration may also preserve a central blood volume and lower pulmonary vascular resistance.
Turning now to
As one example, the lower body 306 may define a substantially horizontal plane. A first angled plane may be defined by a line formed from the patient's chest 304 (heart and lungs) to his shoulder blades. A second angled plane may be defined by a line from the shoulder blades to the head 302. The first plane may be angled about between 5° and 15° above the substantially horizontal plane and the second plane may be at an angle of between about 15° and 45° above the substantially horizontal plane.
Lower support 308 and/or upper support 310 may be wedges used to prop up the head and/or thorax of a patient. In some embodiments, a CPR wedge may be formed of a rigid material so that the patient, and the patient's back, neck and head, may be held in a substantially stationary position while CPR is performed. In some embodiments, a CPR wedge may be inflatable. A CPR wedge may be “hollow” so that any of a variety of tools such as CPR tools and an automated external defibrillator (AED), for example, may be stored therein. In some embodiments a backboard may be used as a support. In other embodiments, a hospital cart or bed may be inclinable such that the head and thorax may be elevated to different heights. It will be appreciated that suitable supports may include any structure providing sufficient support to maintain a patient in the described elevated position while undergoing CPR administration. While shown here with two supports having different heights and angles, it will be appreciated that one or more supports having the same angle relative to horizontal may be used to position the head 302 above the thorax 304, which is positioned above the lower body 306. The patient 300 may receive CPR in this elevated position.
In some embodiments, the support structure may include one or more of a flat portions, each having a constant angle of elevation relative to a substantially horizontal plane. In other embodiments, the support structure may have one or more contoured or curved portions, each having a variable angle of elevation relative to the horizontal plane. This may help the support structure more closely match natural contours of the human body. In some embodiments, a combination of flat and contoured portions may be used.
The type of CPR being performed on the elevated patient may vary. Examples of CPR techniques that may be used include manual chest compression, chest compressions using an assist device such as assist device 312, either automated or manually, ACD CPR, load-distributing band, standard CPR, stutter CPR, and the like. Such processes and techniques are described in U.S. Pat. Pub. No. 2011/0201979 and U.S. Pat. Nos. 5,454,779 and 5,645,522, all incorporated herein by reference. Further various sensors may be used in combination with one or more controllers to sense physiological parameters as well as the manner in which CPR is being performed. The controller may be used to vary the manner of CPR performance, adjust the angle of inclination, provide feedback to the rescuer, and the like. Further, a compression device could be simultaneously applied to the lower extremities to squeeze venous blood back into the upper body, thereby augmenting blood flow back to the heart.
Additionally, a number of other procedures may be performed while CPR is being performed on the patient in the torso-elevated state. One such procedure is to periodically prevent or impede the flow in respiratory gases into the lungs. This may be done by using a threshold valve, sometimes also referred to as an impedance threshold device (ITD), that is configured to open once a certain negative intrathoracic pressure is reached. The invention may utilize any of the threshold valves or procedures using such valves that are described in U.S. Pat. Nos. 5,551,420; 5,692,498; 5,730,122; 6,029,667; 6,062,219; 6,155,257; 6,234,916; 6,224,562; 6,526,973; 6,604,523; 6,986,349; and 7,204,251, the complete disclosures of which are herein incorporated by reference.
Another such procedure is to manipulate the intrathoracic pressure in other ways, such as by using a ventilator or other device to actively withdraw gases from the lungs. Such techniques as well as equipment and devices for regulating respirator gases are described in U.S. Pat. Pub. No. 2010/0031961, incorporated herein by reference. Such techniques as well as equipment and devices are also described in U.S. patent application Ser. Nos. 11/034,996 and 10/796,875, and also U.S. Pat. Nos. 5,730,122; 6,029,667; 7,082,945; 7,185,649; 7,195,012; and 7,195,013, the complete disclosures of which are herein incorporated by reference.
In some embodiments, the angle and/or height of the head and/or heart may be dependent on a type of CPR performed and/or a type of intrathoracic pressure regulation performed. For example, when CPR is performed with a device or device combination capable of providing more circulation during CPR, the head may be elevated higher, for example 10-30 cm above the horizontal plane (10-45 degrees) such as with ACD+ITD CPR. When CPR is performed with less efficient means, such as manual conventional standard CPR, then the head will be elevated less, for example 5-20 cm or 10 to 20 degrees.
In such embodiments, the two angled planes may be a single surface or may be separate surfaces. In some embodiments, one or both of the first angled plane 402 and the second angled plane 404 may be adjustable such that a height and/or angle of the plane may be adjusted to match a particular type of CPR and/or ITP regulation being administered to a patient. The planes may also be adjusted to handle patients of various sizes, as a distance between the patient's head and heart may be far away from an average value that the patient may necessitate a different angle for one or both of the first angled plane 402 and the second angled plane 404 to achieve desired heights of the head and heart.
A variety of equipment or devices may be coupled to or associated with the structure used to elevate the head and torso to facilitate the performance of CPR and/or intrathoracic pressure regulation. For example, a coupling mechanism, connector, or the like may be used to removably couple a CPR assist device to the structure. This could be as simple as a snap fit connector to enable a CPR assist device to be positioned over the patient's chest. Examples of CPR assist devices that could be used with the support structure (either in the current state or a modified state) include the Lucas device, sold by Physio-Control, Inc. and described in U.S. Pat. No. 7,569,021, the entire contents of which is hereby incorporated by reference, the Defibtech Lifeline ARM—Hands-Free CPR Device, sold by Defibtech, the Thumper mechanical CPR device, sold by Michigan Instruments, automated CPR devices by Zoll, the AutoPulse, U.S. Pat. No. 7,056,296, the entire contents of which is hereby incorporated by reference, and the like.
Similarly, various commercially available intrathoracic pressure devices could be removably coupled to the support structure. Examples of such devices include the Lucas device (Physio-control) U.S. Pat. No. 7,569,021, the Weil Mini Chest Compressor Device, U.S. Pat. No. 7,060,041 (Weil Institute), the entire contents of which is hereby incorporated by reference, the Zoll AutoPulse, and the like.
Second portion 504 may include positioning features to help medical personnel properly position the patient. For example, indentations 510 and 512 may indicate where to position the patient's shoulders and head, respectively. In some embodiments, a neck support, such as a pad or pillow or other protrusion, may be included. This may help support the neck and allow the patient's head to rest on the second portion 504. In some embodiments, the second portion 504 may also include a coupling for an ITD device to be secured to the support structure 500, or any of the other intrathoracic pressure regulation devices described herein.
During administration of various types of head and thorax up CPR, it is advantageous to maintain the patient in the “Sniffing Position” where the patient is properly situated for endotracheal intubation. In such a position, the neck is flexed and the head extended, allowing for patient intubation and airway management. During elevation of the upper body, the Sniffing Position may require that a center of rotation of an upper support structure supporting the patient's head be co-incident to a center of rotation of the upper head and neck region. The center of rotation of the upper head and neck region may be in a region of the spinal axis and the scapula region. Maintaining the Sniffing Position of the patient may be done in several ways.
To achieve the adjustability of angles and/or heights, the lower support 908 and/or upper support 904 may be elevated using a motor and corresponding linkage. For example, the lower support 908 may be coupled to a lower support structure motor 912 and lower support structure linkage 914. The lower support structure motor 912 may be coupled with a base 916 of the support structure 900. The lower support structure motor 912 may be coupled with the lower support 908 using lower support structure linkage 914, which may shorten and extend as the lower support 908 raises and lowers. The lower support 908 may adjust to elevation angles between about 5° and 30° above a horizontal plane 918 such that the head is elevated about 3 cm and 8 cm above the horizontal plane 918. A similar motor and/or linkage may be coupled with the upper support 904 and/or a portion of the lower support 908 and/or base 916. The upper support 904 may be elevated at an angle of between about 20° and 45° above the horizontal plane 918 such that the head is at a height of between about 10 cm and 30 cm relative to the horizontal plane 918.
It will be appreciated that adjustment mechanisms other than motors may be utilized. For example, manual gear and/or ratcheting mechanisms may be used to adjust and maintain a support in a desired position.
In some embodiments, the motors may be coupled with a processor or other computing device. The computing device may communicate with one or more input devices such as a keypad, and/or may couple with sensors such as flow and pressure sensors. This allows a user to select an angle and/or height of the heart and/or head. Additionally, sensor inputs may be used to automatically control the motor and angle of the supports based on flow and pressure measurements, as well as a type of CPR and/or ITP regulation.
In some embodiments, support structure 900 may include a neck support that helps maintain the patient's head and neck in the Sniffing Position. A vertical height of the neck support relative to the upper support 904 may be adjustable to accommodate patients of different sizes. Additionally, the lateral position of the neck support may be adjustable to further accommodate various patients and ensure that each patient is in the optimal Sniffing Position.
In some embodiments, a support structure such as support structure 900 may have a static preset thoracic angle that is nominally level. Such a support structure permits manual and/or automatic CPR while the upper head/neck/shoulders are elevated while the support structure is in operation to improve circulatory performance. Increased elevation angles are important due to various factors, such as a type of CPR, a type of ITP regulation, and/or based on physiological factors [e.g. blood pressure]. Important features of this elevation are the height of the heart and the height of the head, which may be measured from the center of mass of the body. To gain greater angles and a more effective CPR process, some embodiments involve inclining the entire upper body in combination with a head and thorax up support structure. In some embodiments, the support structure is configured to rotate the entire thoracic region during manual and/or automated CPR. This may be accomplished by utilizing a geared motor with a worm gear or screw such that the force generated by the motor is correctly applied to a fulcrum to cause the entire thoracic region, including the head and neck, along with any apparatus being used for the purpose of manual and/or automated CPR and any device for controlling the motion of the head and neck for various purposes, such as airway management, to be elevated.
While shown as being positioned under an entire torso of the patient, it will be appreciated that the support structure may be positioned under only a portion of the upper body, such as just the portion above the ribcage. In each embodiment of support structure described herein, the positioning of the support structure may be such that the heart and head are elevated to a desired height and/or angle relative to a horizontal plane.
In some embodiments, a portion of a neck support may be positioned over a near frictionless track or surface, such as, but not limited to, a surface constructed of Polytetrafluoroethylene (PTFE). This allows the head and neck, while in the Sniffing Position, to slide vertically on an axis aligned or near aligned with the support structure. The neck support may have a small spring force to assist motion of the neck support and to counter any residual effects or effects due to gravity, and assures optimal placement of the patient in the Sniffing Position. Outline portion 1300 of support structure 1302 in
While shown here as a sleeve, it will be appreciated that some embodiments may utilize a channel or indentation to receive a backplate of a chest compression device. Other embodiments may include one or more fastening mechanisms, such as snaps, clamps, magnets, hook and loop fasteners, and the like to secure a backplate onto a support structure. In some embodiments, a backplate may be permanently built into the support structure. For example, a thorax-supporting or lower portion of a support structure may be shaped to match a patient's back and may include one or more mounting features that may engage or be engaged with corresponding mounting features of a chest compression device.
Support structure 1600 may also include non-slip pads 1606 and 1608 that further help maintain the patient in the correct position without slipping. Non-slip pad 1606 may be positioned on a lower or thorax support 1612, and non-slip pad 1608 may be positioned on an upper or head and neck support 1614. While not shown, it will be appreciated that a neck support, such as described elsewhere herein, may be included in support structure 1600. Support structure 1600 may also include motor controls 1610. Motor controls 1610 may allow a user to control a motor to adjust an angle of elevation and/or height of the lower support 1612 and/or upper support 1614. For example, an up button may raise the elevation angle, while a down button may lower the elevation angle. A stop button may be included to stop the motor at a desired height, such as an intermediate height between fully elevated and supine. It will be appreciated that motor controls 1610 may include other features, and may be coupled with a computing device and/or sensors that may further adjust an angle of elevation and/or a height of the lower support 1612 and/or the upper support 1614 based on factors such as a type of CPR, a type of ITP regulation, a patient's body size, measurements from flow and pressure sensors, and/or other factors.
One or both of a type of CPR or a type of intrathoracic pressure regulation may be performed when the patient is flat and then while elevating the heart and the head at block 1808. The first height and the second height may be determined based on one or both of the type of CPR or the type of intrathoracic pressure regulation. In some embodiments, the patient's head will be maintained continuously in the “sniffing position” when flat and elevated. Elevation of the thorax and elevation of the head to a greater height than the thorax assists to 1) lower intracranial pressure and increase cerebral perfusion pressure during the performance of CPR and 2) lower right atrial pressure and increase coronary perfusion pressure during the performance of CPR. In some embodiments, the process 1800 may also include coupling one or both of a device for regulating intrathoracic pressure or a CPR assist device to a structure supporting one or both of the head and the heart.
CPR may be performed by repeatedly compressing the chest at block 1908, whereby elevation of the heart and elevation of the head to a greater height than the thorax assists to 1) lower intracranial pressure and increase cerebral perfusion pressure during the performance of CPR and 2) lower right atrial pressure and increase coronary perfusion pressure during the performance of CPR. Performing CPR may include performing one or more of standard conventional CPR, stutter CPR, an active compression decompression CPR; a thoracic band with phased CPR; an automated CPR using a device that performs CPR according to an algorithm. At block 1910, the intrathoracic pressure of the individual may be regulated while performing CPR. In some embodiments, the first angle and the second angle may be determined based on a type of CPR performed and a type of intrathoracic pressure regulation. In some embodiments, process 1900 may include interfacing a chest compression device to the chest of the individual and/or interfacing an impedance threshold device with the airway of the individual to create a negative pressure within the chest during a relaxation phase of CPR.
The elevation of the head alone lowers ICP and thus will result in higher cerebral perfusion pressure compared with CPR administered to a flat or supine patient. Elevation of the head and thorax lowers ICP and shifts the distribution of blood in the lung fields and in the right heart such that there is a net greater blood flow across the lungs because with elevation of the thorax the upper lung fields are less congested than when flat, allowing for greater gas exchange and less resistance to blood flow. This increases blood flow to the brain and the heart. Both elevating only a patient's head, as well as elevating both the head and thorax, are more effective than tilting the whole body upwards because over time with the whole body tilted, blood pools in the lower body, which results in there being less blood to circulation to the brain and heart over time. Elevation of the head alone, head and thorax, or whole body, are each better than flat CPR, since with flat CPR the 1) pulmonary vascular resistance is higher and thus there is a decreased net blood flow from the right heart to the left heart and 2) there are simultaneous compression waves to the brain via the veins on one side and the arteries on the other. Any time the head is elevated, it is necessary to ensure there is enough of a pressure head to perfuse the elevated brain. Conventional CPR does not provide adequate enough perfusion, and instead intrathoracic pressure regulators like the ITD are often needed to increase circulation and thus provide sufficient perfusion to drive blood upwards, against gravity, to the brain, when CPR is performed in the head up position, regardless of whether it is whole body upward tilt, head up alone or head and thorax elevation as described herein.
Additional information and techniques related to head up CPR may be found in Debaty G, et al. “Tilting for perfusion: Head-up position during cardiopulmonary resuscitation improves brain flow in a porcine model of cardiac arrest.” Resuscitation. 2015: 87: 38-43. Print., the entire contents of which is hereby incorporated by reference. Further reference may be made to Lurie, Keith G. “The Physiology of Cardiopulmonary Resuscitation,” which is attached to this application as Appendix A, the entire contents of which are hereby incorporated by reference. Moreover, any of the techniques and methods described therein may be used in conjunction with the systems and methods of the present invention.
An experiment was performed to determine whether cerebral and coronary perfusion pressures will remain elevated over 20 minutes of CPR with the head elevated at 15 cm and the thorax elevated at 4 cm compared with the supine position. A trial using female farm pigs was performed, modeling prolonged CPR for head-up versus head flat during both C-CPR and ACD+ITD CPR. A porcine model was used and focus was placed primarily on observing the impact of the position of the head on cerebral perfusion pressure and ICP.
Approval for the study was obtained from the Institutional Animal Care Committee of the Minneapolis Medical Research Foundation, the research foundation associated with Hennepin County Medical Center in Minneapolis, MN. Animal care was compliant with the National Research Council's 1996 Guidelines for the Care and Use of Laboratory Animals, and a certified and licensed veterinarian assured protocol performance was in compliance with these guidelines. This research team is qualified and has extensive combined experience performing CPR research in Yorkshire female farm pigs.
The animals were fasted overnight. Each animal received intramuscular ketamine (10 mL of 100 mg/mL) for initial sedation, and were then transferred from their holding pen to the surgical suite and intubated with a 7-8 French endotracheal tube. Anesthesia with inhaled isoflurane at 0.8%-1.2% was then provided, and animals were ventilated with room air using a ventilator with tidal volume 10 mL/kg. Arterial blood gases were obtained at baseline. The respiratory rate was adjusted to keep oxygen saturation above 92% and end tidal carbon dioxide (ETCO2) between 36 and 40 mmHg. Central aortic blood pressures were recorded continuously with a micromanometer-tipped catheter placed in the descending thoracic aorta via femoral cannulation at the level of the diaphragm. A second Millar catheter was placed in the right external jugular vein and advanced into the superior vena cava, approximately 2 cm above the right atrium for measurement of right atrial (RA) pressure. Carotid artery blood flows were obtained by placing an ultrasound flow probe in the left common carotid artery for measurement of blood flow (ml Intracranial pressure (ICP) was measured by creating a burr hole in the skull, and then insertion of a Millar catheter into the parietal lobe. All animals received a 100 units/kg bolus of heparin intravenously and received a normal saline bolus for a goal right atrial pressure of 3-5 mmHg. ETCO2 and oxygen saturation were recorded with a CO2SMO Plus®.
Continuous data including electrocardiographic monitoring, aortic pressure, RA pressure, ICP, carotid blood flow, ETCO2 was monitored and recorded. Cerebral perfusion pressure (CerPP) was calculated as the difference between mean aortic pressure and mean ICP. Coronary perfusion pressure (CPP) was calculated as the difference between aortic pressure and RA pressure during the decompression phase of CPR. All data was stored using a computer data analysis program.
When the preparatory phase was complete, ventricular fibrillation (VF) was induced with delivery of direct intracardiac electrical current from a temporary pacing wire placed in the right ventricle. Standard CPR and ACD+ITD CPR were performed with a pneumatically driven automatic piston device. Standard CPR was performed with uninterrupted compressions at 100 compressions/min, with a 50% duty cycle and compression depth of 25% of anteroposterior chest diameter. During standard CPR, the chest wall was allowed to recoil passively. ACD+ITD CPR was also performed at a rate of 100 per minute, and the chest was pulled upwards after each compression with a suction cup on the skin at a decompression force of approximately 20 lb and an ITD was placed at the end of the endotracheal tube. If randomization called for head and thorax elevation CPR (HUP), the head and shoulders of the animal were elevated 15 cm on a table specially built to bend and provide CPR at different angles (
After 8 minutes of untreated ventricular fibrillation 2 minutes of automated CPR was performed in the 0° supine (SUP) position. Pigs were then randomized to CPR with 30° head and thorax up (HUP) versus SUP without interruption for 20 minutes. In group A, all pigs received C-CPR, randomized to either HUP or SUP, and in Group B, all pigs received ACD+ITD CPR, again randomized to either HUP or SUP. After 22 total minutes of CPR, all pigs were then placed in the supine position and defibrillated with up to three 275 J biphasic shocks. Epinephrine (0.5 mg) was also given during the post CPR resuscitation. Animals were then sacrificed with a 10 ml injection of saturated potassium chloride.
The estimated the mean cerebral perfusion pressure was 28 mmHg in the HUP ACD+ITD group and 19 mmHg in the SUP ACD+ITD group, with a standard deviation of 8. Assuming an alpha level of 0.05 and 80% power, it was calculated that roughly 13 animals per group were needed to detect a 47% difference.
Descriptive statistics were used as appropriate. An unpaired t-test was used for the primary outcome comparing CerPP between HUP and SUP CPR. This was done both for the ACD+ITD CPR group and also the C-CPR group at 22 minutes. All statistical tests were two-sided, and a p value of less than 0.05 was required to reject the null hypothesis. Data are expressed as mean±standard error of mean (SEM). Secondary outcomes of coronary perfusion pressure (CPP, mmHg), time to first gasp (seconds), and return of spontaneous circulation (ROSC) were also recorded and analyzed.
Group A:
Table 1A below summarizes the results for group A.
Both HUP and SUP cerebral perfusion pressures were similar at baseline. Seven pigs were randomized to each group. For the primary outcome, after 22 minutes of C-CPR, CerPP in the HUP group was significantly higher than the SUP group (6±3 mmHg versus
−5±3 mmHg, p=0.016).
Elevation of the head and shoulders resulted in a consistent reduction in decompression phase ICP during CPR compared with the supine controls. Further, the decompression phase right atrial pressure was consistently lower in the HUP pigs, perhaps because the thorax itself was slightly elevated. Coronary perfusion pressure was 6±2 mmHg in the HUP group and 3±2 mmHg in the SUP group at 20 minutes (p=0.283) (Table 1A). None of the pigs treated with C-CPR, regardless of the position of the head, could be resuscitated after 22 minutes of CPR.
Time to first gasp was 306±79 seconds in the HUP group and 308±37 in the SUP group (p=0.975). Of note, 3 animals in the HUP group and 2 animals in the SUP group were not observed to gasp during the resuscitation.
Group B:
Table 1B below summarizes the results for group B.
Both HUP and SUP cerebral perfusion pressures were similar at baseline. Eight pigs were randomized to each group. For the primary outcome, after 22 minutes of ACD+ITD CPR, CerPP in the HUP group was significantly higher than the SUP group (51±8 mmHg versus 20±5 mmHg, p=0.006). The elevation of cerebral perfusion pressure was constant over time with ACD+ITD plus differential head and thorax elevation. This is shown in
In pigs treated with ACD+ITD, the systolic blood pressure was significantly higher after 20 minutes of CPR in the HUP position compared with controls and the decompression phase right atrial pressures were significantly lower in the HUP pigs. Further, the ICP was significantly reduced during ACD+ITD CPR with elevation of the head and shoulders compared with the supine controls.
Coronary perfusion pressure was 32±5 mmHg in the HUP group and 19±5 mmHg in the SUP group at 20 minutes (p=0.074) (Table 1B). Both groups had a similar ROSC rate; 6/8 swine could be resuscitated in both groups.
Time to first gasp was 280±27 seconds in the HUT group and 333±33 seconds in the SUP group (p=0.237).
The primary objective of this study was to determine if elevation of the head by 15 cm and the heart by 4 cm during CPR would increase the calculated cerebral and coronary perfusion pressure after a prolonged resuscitation effort. The hypothesis stated that elevation of the head would enhance venous blood drainage back to the heart and thereby reduce the resistance to forward arterial blood flow and differentially reduce the venous pressure head the bombards the brain with each compression, as the venous vasculature is significantly more compliance than the arterial vasculature. The hypothesis further included that a slight elevation of the thorax would result in higher systolic blood pressures and higher coronary perfusion pressures based upon the following physiological concepts. A small elevation of the thorax, in the study 4 cm, was hypothesized to create a small but importance gradient across the pulmonary vascular beds, with less congestion in the more cranial lungs fields since elevation of the thorax would cause more blood to pool in the lower lung fields. This would allow for better gas exchange in the upper lung fields and lower pulmonary vascular resistance in the congested upper lung fields, allowing more blood to flow from the right heart through the lungs to the left ventricle when compared to CPR in the flat or supine position. In contrast to a previous study with the whole body head up tilt, where there was a concern about a net decrease in central blood volume over time in greater pooling of venous blood over time in the abdomen and lower extremities, it was hypothesized that the small 4 cm elevation of the thorax with greater elevation of the head would provide a way to increase coronary pressure pressures (by lower right atrial pressure) and greater cerebral perfusion pressure (by lowering ICP) while preserving central blood volume and thus mean arterial pressure.
It has been previously reported that whole body head tilt up at 30° during CPR significantly improves cerebral perfusion pressure, coronary perfusion pressure, and brain blood flow as compared to the supine, or 0° position or the feet up and head down position after a relatively short duration of 5 minutes of CPR. Over time these effects were observed to decrease, and we hypothesized diminished effect over time was secondary to pooling of blood in the abdomen and lower extremities. The new results demonstrate that after a total time of 22 minutes of CPR, the absolute ICP values and the calculated CerPP were significantly higher in the head and shoulders up position versus the supine position for both automated C-CPR and ACD+ITD groups. The absolute HUP effect was modest in the C-CPR group, unlikely to be clinically significant, and none of the animals treated with C-CPR could be resuscitated. By contrast, differential elevation of the head by 15 cm and the thorax at the level of the heart by 4 cm in the ACD+ITD group resulted in a nearly 3-fold higher increase in the calculated CerPP and a 50% increase in the calculated coronary perfusion pressure after 22 minutes of continuous CPR. The new finding of increased coronary and CerPP in the HUP position during a prolonged ACD+ITD CPR effort is clinically important, since the average duration of CPR during pre-hospital resuscitation is often greater than 20 minutes and average time from collapse to starting CPR is often >7 minutes.
Other study endpoints included ROSC and time to first gasp as an indicator of blood flow to the brain stem. No pigs could be resuscitated after 22 minutes in the C-CPR group. ROSC rates were similar in Group B, with 6/8 having ROSC in both HUP and SUP groups.
From a physiological perspective, these findings are similar to those in the first whole body head up tilt CPR study. While ICP decreases with the HUP position, it is critical to maintain enough of an arterial pressure head to pump blood upwards to the elevated brain during HUP CPR. In a previous HUP study, removal of the ITD from the circuit resulted in an immediate decrease in systolic blood pressure. In the current study, the arterial pressures were lower in pigs treated with C-CPR versus ACD+ITD, both in the SUP and HUP positions. It is likely that the lack of ROSC in the pigs treated with C-CPR is a reflection of the limitations of conventional CPR where coronary and cerebral perfusion is far less than normal. As such, the absolute ROSC rates in the current study are similar to previous animal studies with ACD+ITD CPR and C-CPR.
Gasping during CPR is positive prognostic indicator in humans. While time to time to first gasp within Groups A and B was not significant, the time to first gasp was the shortest in the ACD+ITD HUP group of all groups. All 16 animals treated with ACD+ITD group gasped during CPR, whereas only 5/16 pigs gasped in the C-CPR group during CPR (3 HUP, 2 SUP).
Differential elevation of the head and thorax during C-CPR and ACD+ITD CPR increased cerebral and coronary perfusion pressures. This effect was constant over a prolonged period of time. The CerPP in the pigs treated with ACD+ITD CPR and the HUP position was nearly 50 mmHg, strikingly higher than the ACD+ITD SUP controls. In addition, the coronary perfusion pressure increased by about 50%, to levels known to be associated with consistently higher survival rates. By contrast, the modest elevation in CerPP in the C-CPR treated animals is likely clinically insignificant, as no pig treated with C-CPR could be resuscitated after 22 minutes of CPR. These observations provide strong support of the benefit of the combination of ACD+ITD CPR with differential elevation of the head and thorax.
Additional data, as shown in
To show head up CPR as described in the multiple embodiments in this application, a human cadaver model was used. The body was donated for science. The cadaver was less than 36 hours old and had never been embalmed or frozen. It was perfused with a saline with a clot disperser solution that breaks up blood clots so that when the head up CPR technology was evaluated there were no blood clots or blood in the blood vessels.
Right atrial, aortic, and intracranial pressure transducers were inserted into the body into the right atria, aorta, and the brain through an intracranial bolt. These high fidelity transducers where then connected to a computer acquisition system (Biopac). CPR was performed with a ACD+ITD CPR in the flat position and then with the head elevated with the device shown in
Then, the Lucas device plus ITD was applied to the cadaver and CPR was performed with the cadaver flat and with head up with a device similar to the device shown in
Specific details are given in the description to provide a thorough understanding of example configurations (including implementations). However, configurations may be practiced without these specific details. For example, well-known processes, structures, and techniques have been shown without unnecessary detail in order to avoid obscuring the configurations. This description provides example configurations only, and does not limit the scope, applicability, or configurations of the claims. Rather, the preceding description of the configurations will provide those skilled in the art with an enabling description for implementing described techniques. Various changes may be made in the function and arrangement of elements without departing from the spirit or scope of the disclosure.
Also, configurations may be described as a process which is depicted as a flow diagram or block diagram. Although each may describe the operations as a sequential process, many of the operations may be performed in parallel or concurrently. In addition, the order of the operations may be rearranged. A process may have additional steps not included in the figure.
Although the subject matter has been described in language specific to structural features and/or methodological acts, it is to be understood that the subject matter defined in the appended claims is not necessarily limited to the specific features or acts described above. Rather, the specific features and acts described above are disclosed as example forms of implementing the claims.
This application is a continuation of U.S. application Ser. No. 17/392,103, filed Aug. 2, 2021, which is a continuation of U.S. application Ser. No. 15/652,023, filed Jul. 17, 2017, now U.S. Pat. No. 11,077,016, which is a continuation of U.S. application Ser. No. 14/935,262, filed Nov. 6, 2015, now U.S. Pat. No. 9,707,152, which claims priority to U.S. Provisional Application No. 62/242,655, filed Oct. 16, 2015, and is also a continuation in part of U.S. application Ser. No. 14/677,562, filed Apr. 2, 2015, now U.S. Pat. No. 10,092,481, which is a continuation of U.S. patent application Ser. No. 14/626,770, filed Feb. 19, 2015, now U.S. Pat. No. 10,245,209, which claims the benefit of U.S. Provisional Application No. 61/941,670, filed Feb. 19, 2014, U.S. Provisional Application No. 62/000,836, filed May 20, 2014 and U.S. Provisional Application No. 62/087,717, filed Dec. 4, 2014, the complete disclosures of which are hereby incorporated by reference for all intents and purposes.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1995583 | Sanderson | Mar 1935 | A |
| 2566351 | Meuler | Sep 1951 | A |
| 2683452 | McCavic | Jul 1954 | A |
| 3461858 | Michelson | Aug 1969 | A |
| 3509899 | Hewson | May 1970 | A |
| 3804082 | Tarjan et al. | Apr 1974 | A |
| 3866604 | Curless et al. | Feb 1975 | A |
| 3870038 | Arblaster | Mar 1975 | A |
| 3931653 | Bien | Jan 1976 | A |
| 3985126 | Barkalow | Oct 1976 | A |
| 4060079 | Reinhold, Jr. | Nov 1977 | A |
| 4095590 | Harrigan | Jun 1978 | A |
| 4168554 | Hindes | Sep 1979 | A |
| 4194732 | Liebman | Mar 1980 | A |
| 4266759 | Liebman | May 1981 | A |
| 4362336 | Zapf et al. | Dec 1982 | A |
| 4534075 | Schnitzler | Aug 1985 | A |
| 4915095 | Chun | Apr 1990 | A |
| 5048136 | Popitz | Sep 1991 | A |
| 5316907 | Lurie et al. | May 1994 | A |
| 5399148 | Waide et al. | Mar 1995 | A |
| 5400448 | Zwickey | Mar 1995 | A |
| 5423772 | Lurie et al. | Jun 1995 | A |
| 5454779 | Lurie et al. | Oct 1995 | A |
| 5487722 | Weaver, II et al. | Jan 1996 | A |
| 5490820 | Schock et al. | Feb 1996 | A |
| 5538002 | Boussignac et al. | Jul 1996 | A |
| 5549581 | Lurie et al. | Aug 1996 | A |
| 5551420 | Lurie et al. | Sep 1996 | A |
| 5588422 | Lurie et al. | Dec 1996 | A |
| 5618665 | Lurie et al. | Apr 1997 | A |
| 5634222 | Zwickey | Jun 1997 | A |
| 5643231 | Lurie et al. | Jul 1997 | A |
| 5645522 | Lurie et al. | Jul 1997 | A |
| 5692498 | Lurie et al. | Dec 1997 | A |
| 5722963 | Lurie et al. | Mar 1998 | A |
| 5730122 | Lurie | Mar 1998 | A |
| 5730136 | Laufer et al. | Mar 1998 | A |
| 5827893 | Lurie et al. | Oct 1998 | A |
| 5919210 | Lurie et al. | Jul 1999 | A |
| 5984909 | Lurie et al. | Nov 1999 | A |
| 6001085 | Lurie et al. | Dec 1999 | A |
| 6029667 | Lurie | Feb 2000 | A |
| 6062219 | Lurie et al. | May 2000 | A |
| 6078834 | Lurie et al. | Jun 2000 | A |
| 6116288 | Yamamura | Sep 2000 | A |
| 6142962 | Mollenauer et al. | Nov 2000 | A |
| 6155257 | Lurie et al. | Dec 2000 | A |
| 6224562 | Lurie et al. | May 2001 | B1 |
| 6234916 | Carusillo et al. | May 2001 | B1 |
| 6234985 | Lurie et al. | May 2001 | B1 |
| 6277107 | Lurie et al. | Aug 2001 | B1 |
| 6312399 | Lurie et al. | Nov 2001 | B1 |
| 6357065 | Adams | Mar 2002 | B1 |
| 6371119 | Zadini et al. | Apr 2002 | B1 |
| 6425393 | Lurie et al. | Jul 2002 | B1 |
| 6446288 | Pi | Sep 2002 | B1 |
| 6446962 | Taffertshofer | Sep 2002 | B1 |
| 6459933 | Lurie et al. | Oct 2002 | B1 |
| 6463327 | Lurie et al. | Oct 2002 | B1 |
| 6486206 | Lurie | Nov 2002 | B1 |
| 6526973 | Lurie et al. | Mar 2003 | B1 |
| 6587726 | Lurie et al. | Jul 2003 | B2 |
| 6604523 | Lurie et al. | Aug 2003 | B2 |
| 6656166 | Lurie et al. | Dec 2003 | B2 |
| 6751818 | Troop | Jun 2004 | B2 |
| 6776156 | Lurie et al. | Aug 2004 | B2 |
| 6810257 | Amin | Oct 2004 | B1 |
| 6863656 | Lurie | Mar 2005 | B2 |
| 6935336 | Lurie et al. | Aug 2005 | B2 |
| 6938618 | Lurie et al. | Sep 2005 | B2 |
| 6986349 | Lurie | Jan 2006 | B2 |
| 7044128 | Lurie et al. | May 2006 | B2 |
| 7056296 | Sherman et al. | Jun 2006 | B2 |
| 7060041 | Weil et al. | Jun 2006 | B1 |
| 7082945 | Lurie | Aug 2006 | B2 |
| 7174891 | Lurie et al. | Feb 2007 | B2 |
| 7185649 | Lurie | Mar 2007 | B2 |
| 7195012 | Lurie | Mar 2007 | B2 |
| 7195013 | Lurie | Mar 2007 | B2 |
| 7204251 | Lurie | Apr 2007 | B2 |
| 7210480 | Lurie et al. | May 2007 | B2 |
| 7275542 | Lurie et al. | Oct 2007 | B2 |
| 7296312 | Menkedick et al. | Nov 2007 | B2 |
| 7311668 | Lurie | Dec 2007 | B2 |
| 7347832 | Jensen et al. | Mar 2008 | B2 |
| 7410649 | Yoshimi et al. | Aug 2008 | B2 |
| 7569021 | Sebelius et al. | Aug 2009 | B2 |
| 7682312 | Lurie | Mar 2010 | B2 |
| 7766011 | Lurie | Aug 2010 | B2 |
| 7836881 | Lurie et al. | Nov 2010 | B2 |
| 7899526 | Benditt et al. | Mar 2011 | B2 |
| 8011367 | Lurie et al. | Sep 2011 | B2 |
| 8108204 | Gabrilovich et al. | Jan 2012 | B2 |
| 8151790 | Lurie et al. | Apr 2012 | B2 |
| 8210176 | Metzger et al. | Jul 2012 | B2 |
| 8291534 | Karlson | Oct 2012 | B2 |
| 8336142 | See et al. | Dec 2012 | B1 |
| 8408204 | Lurie | Apr 2013 | B2 |
| 8690807 | Hiebert | Apr 2014 | B2 |
| 8702633 | Voss et al. | Apr 2014 | B2 |
| 8752220 | Soderberg et al. | Jun 2014 | B2 |
| 8755902 | Lurie et al. | Jun 2014 | B2 |
| 8763610 | Schmidt | Jul 2014 | B2 |
| 8967144 | Lurie et al. | Mar 2015 | B2 |
| 9107800 | Sebelius et al. | Aug 2015 | B2 |
| 9707152 | Lurie et al. | Jul 2017 | B2 |
| 9750661 | Lurie et al. | Sep 2017 | B2 |
| 9801782 | Lurie et al. | Oct 2017 | B2 |
| 10092481 | Lurie | Oct 2018 | B2 |
| 10245209 | Lurie | Apr 2019 | B2 |
| 10350137 | Lurie et al. | Jul 2019 | B2 |
| 10406068 | Lurie et al. | Sep 2019 | B2 |
| 10406069 | Lurie et al. | Sep 2019 | B2 |
| 10667987 | Lurie | Jun 2020 | B2 |
| 11020314 | Lurie | Jun 2021 | B2 |
| 11077016 | Lurie et al. | Aug 2021 | B2 |
| 11096861 | Lurie | Aug 2021 | B2 |
| 11246794 | Lurie | Feb 2022 | B2 |
| 11259988 | Lurie et al. | Mar 2022 | B2 |
| 11395786 | Lurie et al. | Jul 2022 | B2 |
| 20020002347 | Kelly et al. | Jan 2002 | A1 |
| 20020069878 | Lurie et al. | Jun 2002 | A1 |
| 20020170562 | Lurie et al. | Nov 2002 | A1 |
| 20030062040 | Lurie et al. | Apr 2003 | A1 |
| 20030181834 | Sebelius et al. | Sep 2003 | A1 |
| 20040016428 | Lurie | Jan 2004 | A9 |
| 20040058305 | Lurie et al. | Mar 2004 | A1 |
| 20040116840 | Cantrell et al. | Jun 2004 | A1 |
| 20040200474 | Lurie | Oct 2004 | A1 |
| 20040211415 | Lurie | Oct 2004 | A1 |
| 20040211416 | Lurie | Oct 2004 | A1 |
| 20040211417 | Lurie | Oct 2004 | A1 |
| 20040231664 | Lurie et al. | Nov 2004 | A1 |
| 20050165334 | Lurie | Jul 2005 | A1 |
| 20050199237 | Lurie | Sep 2005 | A1 |
| 20050217677 | Lurie et al. | Oct 2005 | A1 |
| 20050267381 | Benditt et al. | Dec 2005 | A1 |
| 20060162077 | McDaniel et al. | Jul 2006 | A1 |
| 20060258964 | Biondo et al. | Nov 2006 | A1 |
| 20060277683 | Lamire et al. | Dec 2006 | A1 |
| 20070021683 | Benditt et al. | Jan 2007 | A1 |
| 20070157385 | Lemire et al. | Jul 2007 | A1 |
| 20070277826 | Lurie | Dec 2007 | A1 |
| 20080045867 | Jensen et al. | Feb 2008 | A1 |
| 20080047555 | Lurie et al. | Feb 2008 | A1 |
| 20080255482 | Lurie | Oct 2008 | A1 |
| 20090062701 | Yannopoulos et al. | Mar 2009 | A1 |
| 20090277447 | Voss et al. | Nov 2009 | A1 |
| 20090308400 | Wilson et al. | Dec 2009 | A1 |
| 20100031961 | Schmidt | Feb 2010 | A1 |
| 20100179442 | Lurie | Jul 2010 | A1 |
| 20100319691 | Lurie et al. | Dec 2010 | A1 |
| 20110030141 | Soderberg et al. | Feb 2011 | A1 |
| 20110047709 | Tarsaud et al. | Mar 2011 | A1 |
| 20110083271 | Bhai | Apr 2011 | A1 |
| 20110098612 | Lurie | Apr 2011 | A1 |
| 20110132377 | Phillips | Jun 2011 | A1 |
| 20110160782 | Lurie et al. | Jun 2011 | A1 |
| 20110201979 | Voss et al. | Aug 2011 | A1 |
| 20110297147 | Lick et al. | Dec 2011 | A1 |
| 20120016179 | Paradis et al. | Jan 2012 | A1 |
| 20120042881 | Paulussen et al. | Feb 2012 | A1 |
| 20120109027 | Gozelski, Jr. et al. | May 2012 | A1 |
| 20120203147 | Lurie et al. | Aug 2012 | A1 |
| 20120260428 | Franklin | Oct 2012 | A1 |
| 20120266383 | Pi | Oct 2012 | A1 |
| 20120330199 | Lurie et al. | Dec 2012 | A1 |
| 20120330200 | Voss et al. | Dec 2012 | A1 |
| 20130231593 | Yannopoulos et al. | Sep 2013 | A1 |
| 20140005566 | Homuth et al. | Jan 2014 | A1 |
| 20140048061 | Yannopoulos et al. | Feb 2014 | A1 |
| 20140082842 | Jackson | Mar 2014 | A1 |
| 20140171839 | Fleming | Jun 2014 | A1 |
| 20140276269 | Illindala | Sep 2014 | A1 |
| 20140324763 | Lurie et al. | Oct 2014 | A1 |
| 20140363391 | Yannopoulos et al. | Dec 2014 | A1 |
| 20150057580 | Illindala | Feb 2015 | A1 |
| 20150231026 | Lurie | Aug 2015 | A1 |
| 20150231027 | Lurie | Aug 2015 | A1 |
| 20160058660 | Lurie et al. | Mar 2016 | A1 |
| 20160128899 | Lurie et al. | May 2016 | A1 |
| 20160228326 | Lurie et al. | Aug 2016 | A1 |
| 20160338904 | Lurie et al. | Nov 2016 | A1 |
| 20160354271 | Ladozhskaya-Gapeenko et al. | Dec 2016 | A1 |
| 20170119622 | Lurie et al. | May 2017 | A1 |
| 20170258677 | Lurie et al. | Sep 2017 | A1 |
| 20180000687 | Lurie et al. | Jan 2018 | A1 |
| 20180008510 | Lurie et al. | Jan 2018 | A1 |
| 20180125749 | Lurie et al. | May 2018 | A1 |
| 20190175444 | Lurie et al. | Jun 2019 | A9 |
| 20190269574 | Lurie | Sep 2019 | A1 |
| 20190282441 | Lurie | Sep 2019 | A1 |
| 20210000685 | Lurie | Jan 2021 | A1 |
| 20210322264 | Lurie | Oct 2021 | A1 |
| 20210361526 | Lurie et al. | Nov 2021 | A1 |
| 20220079839 | Lurie | Mar 2022 | A1 |
| 20220110826 | Lurie | Apr 2022 | A1 |
| 20220265509 | Lurie et al. | Aug 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 2016337605 | Jul 2021 | AU |
| 3002244 | Apr 2017 | CA |
| 107343847 | Nov 2017 | CN |
| 2289477 | Mar 2011 | EP |
| 2308440 | Apr 2011 | EP |
| 3107516 | Dec 2016 | EP |
| 3362028 | Aug 2018 | EP |
| 6890130 | May 2021 | JP |
| 200934469 | Aug 2009 | TW |
| 0128484 | Apr 2001 | WO |
| 2015026460 | Feb 2015 | WO |
| 2015127102 | Aug 2015 | WO |
| 2015127102 | Nov 2015 | WO |
| 2017066770 | Apr 2017 | WO |
| 2019125682 | Jun 2019 | WO |
| Entry |
|---|
| U.S. Appl. No. 17/392,103, Notice of Allowance, dated Mar. 15, 2023, 8 pages. |
| U.S. Appl. No. 17/559,637, Non-Final Office Action, dated Mar. 30, 2023, 10 pages. |
| Author Unknown, “Lucas 3 Chest Compression System”, Retrieved from https://www.physiocontrol.com/WCProductDetails.aspx?id=2147484788&langtype=5129, Accessed from Internet on Aug. 5, 2021, pp. 1-2. |
| Author Unknown, “Lucas CPR”, Chest Compression System, Retrieved from http://www.lucas-cpr.com/en/lucas_cpr/lucas_cpr, Accessed from Internet on Sep. 7, 2018, 16 pages. |
| Author Unknown, “The System for High-Quality CPR”, Retrieved from https://www.zoll.com/medical-technology/cpr, Accessed from Internet on Sep. 14, 2018, 2 pages. |
| U.S. Appl. No. 14/626,770, “Corrected Notice of Allowability”, dated Jan. 4, 2019, 2 pages. |
| U.S. Appl. No. 14/626,770, Non-Final Office Action, dated Sep. 27, 2017, 10 pages. |
| U.S. Appl. No. 14/626,770, Non-Final Office Action, dated Oct. 16, 2017, 11 pages. |
| U.S. Appl. No. 14/626,770, Non-Final Office Action, dated Jun. 7, 2018, 9 pages. |
| U.S. Appl. No. 14/626,770, Notice of Allowance, dated Dec. 14, 2018, 5 pages. |
| U.S. Appl. No. 14/677,562, Advisory Action, dated Jul. 11, 2016, 4 pages. |
| U.S. Appl. No. 14/677,562, “Corrected Notice of Allowability”, dated Sep. 4, 2018, 2 pages. |
| U.S. Appl. No. 14/677,562, Final Office Action, dated Jan. 9, 2017, 13 pages. |
| U.S. Appl. No. 14/677,562, Final Office Action, dated Jan. 23, 2018, 9 pages. |
| U.S. Appl. No. 14/677,562, Final Office Action, dated May 27, 2016, 9 pages. |
| U.S. Appl. No. 14/677,562, Non-Final Office Action, dated Sep. 24, 2015, 12 pages. |
| U.S. Appl. No. 14/677,562, Non-Final Office Action, dated Sep. 6, 2016, 12 pages. |
| U.S. Appl. No. 14/677,562, Non-Final Office Action, dated Jan. 6, 2016, 9 pages. |
| U.S. Appl. No. 14/677,562, Non-Final Office Action, dated Jun. 13, 2017, 9 pages. |
| U.S. Appl. No. 14/677,562, Notice of Allowance, dated Jul. 23, 2018, 9 pages. |
| U.S. Appl. No. 14/935,262, “Corrected Notice of Allowability”, dated May 4, 2017, 6 pages. |
| U.S. Appl. No. 14/935,262, Non-Final Office Action, dated Sep. 9, 2016, 13 pages. |
| U.S. Appl. No. 14/935,262, Notice of Allowance, dated Jan. 4, 2017, 10 pages. |
| U.S. Appl. No. 14/935,262, “Restriction Requirement”, dated Jun. 2, 2016, 7 pages. |
| U.S. Appl. No. 14/996,147, Non-Final Office Action, dated Aug. 26, 2016, 15 pages. |
| U.S. Appl. No. 14/996,147, “Notice of Abandonment”, dated May 8, 2017, 1 page. |
| U.S. Appl. No. 14/996,147, Notice of Allowance, dated Jan. 18, 2017, 12 pages. |
| U.S. Appl. No. 14/996,147, “Restriction Requirement”, dated Jul. 18, 2016, 7 pages. |
| U.S. Appl. No. 15/133,967, Advisory Action, dated Jun. 7, 2017, 3 pages. |
| U.S. Appl. No. 15/133,967, Final Office Action, dated Mar. 13, 2017, 26 pages. |
| U.S. Appl. No. 15/133,967, Non-Final Office Action, dated Oct. 11, 2016, 21 pages. |
| U.S. Appl. No. 15/133,967, Notice of Allowance, dated Jul. 5, 2017, 10 pages. |
| U.S. Appl. No. 15/133,967, “Notice of Publication”, dated Aug. 11, 2016, 1 page. |
| U.S. Appl. No. 15/160,492, Advisory Action, dated Dec. 3, 2018, 3 pages. |
| U.S. Appl. No. 15/160,492, Advisory Action, dated Oct. 3, 2019, 4 pages. |
| U.S. Appl. No. 15/160,492, Final Office Action, dated Aug. 9, 2018, 15 pages. |
| U.S. Appl. No. 15/160,492, Final Office Action, dated Jul. 11, 2019, 15 pages. |
| U.S. Appl. No. 15/160,492, Non-Final Office Action, dated Jan. 11, 2018, 15 pages. |
| U.S. Appl. No. 15/160,492, Non-Final Office Action, dated Dec. 13, 2018, 17 pages. |
| U.S. Appl. No. 15/160,492, Non-Final Office Action, dated Nov. 1, 2019, 19 pages. |
| U.S. Appl. No. 15/160,492, Notice of Allowance, dated Oct. 20, 2021, 8 pages. |
| U.S. Appl. No. 15/285,063, Advisory Action, dated Dec. 20, 2018, 3 pages. |
| U.S. Appl. No. 15/285,063, Final Office Action, dated May 11, 2018, 19 pages. |
| U.S. Appl. No. 15/285,063, Non-Final Office Action, dated Jan. 12, 2018, 17 pages. |
| U.S. Appl. No. 15/285,063, Non-Final Office Action, dated Jan. 28, 2019, 18 pages. |
| U.S. Appl. No. 15/285,063, Notice of Allowance, dated Jul. 17, 2019, 5 pages. |
| U.S. Appl. No. 15/601,494, “Corrected Notice of Allowability”, dated May 30, 2019, 2 pages. |
| U.S. Appl. No. 15/601,494, Notice of Allowance, dated Apr. 10, 2019, 10 pages. |
| U.S. Appl. No. 15/652,023, Advisory Action, dated Mar. 16, 2020, 3 pages. |
| U.S. Appl. No. 15/652,023, Advisory Action, dated Feb. 24, 2021, 4 pages. |
| U.S. Appl. No. 15/652,023, Final Office Action, dated Jan. 9, 2020, 14 pages. |
| U.S. Appl. No. 15/652,023, Final Office Action, dated Nov. 17, 2020, 18 pages. |
| U.S. Appl. No. 15/652,023, Non-Final Office Action, dated Jun. 28, 2019, 13 pages. |
| U.S. Appl. No. 15/652,023, Non-Final Office Action, dated May 1, 2020, 14 pages. |
| U.S. Appl. No. 15/652,023, Notice of Allowance, dated Apr. 2, 2021, 8 pages. |
| U.S. Appl. No. 15/689,670, Final Office Action, dated Apr. 16, 2020, 16 pages. |
| U.S. Appl. No. 15/689,670, Non-Final Office Action, dated Oct. 4, 2019, 10 pages. |
| U.S. Appl. No. 15/689,670, Notice of Allowance, dated Mar. 11, 2022, 9 pages. |
| U.S. Appl. No. 15/796,579, Advisory Action, dated Jun. 24, 2020, 4 pages. |
| U.S. Appl. No. 15/796,579, Final Office Action, dated Feb. 25, 2021, 15 pages. |
| U.S. Appl. No. 15/796,579, Final Office Action, dated Apr. 16, 2020, 9 pages. |
| U.S. Appl. No. 15/796,579, Non-Final Office Action, dated Aug. 6, 2020, 13 pages. |
| U.S. Appl. No. 15/796,579, Non-Final Office Action, dated Oct. 4, 2019, 9 pages. |
| U.S. Appl. No. 15/850,827, Notice of Allowance, dated Feb. 3, 2020, 12 pages. |
| U.S. Appl. No. 15/986,466, First Action Interview Office Action Summary, dated Jan. 7, 2019, 6 pages. |
| U.S. Appl. No. 15/986,466, First Action Interview Pilot Program Pre-Interview Communication, dated Oct. 17, 2018, 4 pages. |
| U.S. Appl. No. 15/986,466, Notice of Allowance, dated Jul. 8, 2019, 12 pages. |
| U.S. Appl. No. 16/058,851, Notice of Allowance, dated Feb. 5, 2021, 21 pages. |
| U.S. Appl. No. 16/418,902, Notice of Allowance, dated Sep. 23, 2021, 13 pages. |
| U.S. Appl. No. 16/432,633, Non-Final Office Action, dated Jan. 14, 2021, 7 pages. |
| U.S. Appl. No. 16/432,633, Notice of Allowance, dated Apr. 21, 2021, 7 pages. |
| U.S. Appl. No. 17/392,103, Non-Final Office Action, dated Nov. 25, 2022, 12 pages. |
| Application No. AU2016337605, “First Examination Report”, dated Jul. 16, 2020, 5 pages. |
| Application No. AU2016337605, “Notice of Acceptance”, dated Jul. 15, 2021, 3 pages. |
| Application No. AU2016337605, “Second Examination Report”, dated Apr. 23, 2021, 4 pages. |
| Application No. CA3,002,244, Office Action, dated Dec. 23, 2022, 3 pages. |
| Debaty, et al., “Tilting for Perfusion: Head-up Position During Cardiopulmonary Resuscitation Improves Brain Flow in a Porcine Model of Cardiac Arrest”, Resuscitation, vol. 87, Feb. 2015, pp. 38-43. |
| Application No. EP15751853.1, Extended European Search Report, dated Oct. 2, 2017, 9 pages. |
| Application No. EP15751853.1, Notice of Decision to Grant, dated Sep. 8, 2022, 3 pages. |
| Application No. EP15751853.1, Office Action, dated Nov. 14, 2019, 9 pages. |
| Application No. EP15751853.1, “Summons to Attend Oral Proceedings”, Sep. 27, 2021, 9 pages. |
| Application No. EP16856418.5, Extended European Search Report, dated Jun. 4, 2019, 8 pages. |
| Application No. EP16856418.5, Notice of Decision to Grant, dated Jul. 23, 2020, 3 pages. |
| Application No. EP18891009.5, Extended European Search Report, dated Sep. 1, 2021, 9 pages. |
| Gocze, et al., “The Effects of the Semirecumbent Position on Hemodynamic Status in Patients on Invasive Mechanical Ventilation: Prospective Randomized Multivariable Analysis”, Critical Care, vol. 17, No. 2, Apr. 26, 2013, 9 pages. |
| Application No. JP2018-539249, Notice of Allowance, dated Apr. 27, 2021, 6 pages. |
| Application No. JP2018-539249, Office Action, dated Oct. 27, 2020, 13 pages. |
| Application No. JP2018-539249, Office Action, dated Feb. 24, 2021, 6 pages. |
| Khandelwal, et al., “Head-Elevated Patient Positioning Decreases Complications of Emergent Tracheal Intubation in the Ward and Intensive Care Unit”, Anesthesia & Analgesia, vol. 122, No. 4, Apr. 2016, pp. 1101-1107. |
| Lurie, “Mechanical Devices for Cardiopulmonary Resuscitation: An Update”, Emergency Medicine Clinics of North America, vol. 20, No. 4, Nov. 2002, pp. 771-784. |
| Lurie, et al., “The Physiology of Cardiopulmonary Resuscitation”, Anesthesia & Analgesia, vol. 122, No. 3, Mar. 2016, pp. 767-783. |
| Moore, et al., “Head and Thorax Elevation During Active Compression Decompression Cardiopulmonary Resuscitation With an Impedance Threshold Device Improves Cerebral Perfusion in a Swine Model of Prolonged Cardiac Arrest”, Resuscitation, Dec. 2017, 1 page. |
| Application No. PCT/US2015/016651, International Preliminary Report on Patentability, dated Sep. 1, 2016, 11 pages. |
| Application No. PCT/US2015/016651, International Search Report and Written Opinion, dated Jul. 8, 2015, 14 pages. |
| Application No. PCT/US2015/016651, “Invitation to Pay Additional Fees and, Where Applicable, Protest Fee”, dated Apr. 27, 2015, 3 pages. |
| Application No. PCT/US2016/057366, International Preliminary Report on Patentability, dated Apr. 26, 2018, 12 pages. |
| Application No. PCT/US2016/057366, International Search Report and Written Opinion, dated Mar. 13, 2017, 15 pages. |
| Application No. PCT/US2016/057366, “Invitation to Pay Additional Fees and, Where Applicable, Protest Fee”, dated Dec. 12, 2016, 2 pages. |
| Application No. PCT/US2018/061789, International Preliminary Report on Patentability, dated Jul. 2, 2020, 8 pages. |
| Application No. PCT/US2018/061789, International Search Report and Written Opinion, dated Feb. 11, 2019, 9 pages. |
| Ryu, et al., “The Effect of Head Up Cardiopulmonary Resuscitation on Cerebral and Systemic Hemodynamics”, Resuscitation, vol. 102, May 2016, pp. 29-34. |
| Song, et al., “Effectiveness of Chest Compression Feedback During Cardiopulmonary Resuscitation in Lateral Tilted and Semirecumbent Positions; A Randomised Controlled Stimulation Study”, Anesthesia, vol. 70, No. 11, Nov. 2015, pp. 1235-1241. |
| Voelckel, et al., “The Effects of Positive End-Expiratory Pressure During Active Compression Decompression Cardiopulmonary Resuscitation with the Inspiratory Threshold Valve”, Anesthesia and Analgesia, vol. 92, No. 4, Apr. 2001, pp. 967-974. |
| Yannopoulos, et al., “Controlled Pauses at the Initiation of Sodium Nitroprusside-enhanced Cardiopulmonary Resuscitation Facilitate Neurological and Cardiac Recovery After 15 Mins of Untreated Ventricular Fibrillation”, Critical Care Medicine, vol. 40, No. 5, May 2012, pp. 1562-1569. |
| Number | Date | Country | |
|---|---|---|---|
| 20230165750 A1 | Jun 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62242655 | Oct 2015 | US | |
| 62087717 | Dec 2014 | US | |
| 62000836 | May 2014 | US | |
| 61941670 | Feb 2014 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17392103 | Aug 2021 | US |
| Child | 18161784 | US | |
| Parent | 15652023 | Jul 2017 | US |
| Child | 17392103 | US | |
| Parent | 14935262 | Nov 2015 | US |
| Child | 15652023 | US | |
| Parent | 14626770 | Feb 2015 | US |
| Child | 14677562 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14677562 | Apr 2015 | US |
| Child | 14935262 | US |
